| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
CG Oncology, Inc.
13D
CGON · 156944100
|
2.0% |
9/18/2025
Event 9/11/2025
|
||||
| Seven Fleet Partners LP | 1.9% | |||||
| Seven Fleet Advisors LLC | 1.9% | |||||
| Brian Liu | 2.0% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
CytomX Therapeutics, Inc.
13G
CTMX · 23284F105
|
0.2% |
5/20/2025
Event 5/13/2025
|
||||
| Seven Fleet Partners LP | 0.2% | |||||
| Seven Fleet Advisors LLC | 0.2% | |||||
| Brian Liu | 0.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.